Also, eukaryotic translation initiation factor 4 gamma 2 (EIF4G2)–GAB1 fusion has been found in patients with non-small cell lung cancer treated with EGFR TKI [74]. Here, EIF4G2 is linked to non-small cell lung carcinoma.